Title
Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way
Author
Hennis, B.C.
Boomsma, D.I.
Fijnvandraat, K.
Gevers Leuven, J.A.
Peters, M.
Kluft, C.
Gaubius Instituut TNO
Publication year
1995
Abstract
Plasma levels of histidine-rich glycoprotein (HRG) were investigated in three groups of women receiving a different dose of estrogens. First, the effect of low-dose estrogen was studied in a group of 83 postmenopausal women who were treated with 0.625 mg conjugated estrogens (CE). No significant change from baseline levels was found at the end of cycle 3 and cycle 13. Secondly, in 15 mothers and 23 daughters using oral contraceptives (OC) containing 30-50 μg ethinyl estradiol (EE) daily the mean HRG level was 14% and 24% lower than in a group of 144 mothers and 134 daughters not taking oral contraceptives, respectively (p < 0.05). Finally, in 11 excessively tall prepuberal girls who received 300 μg EE daily to reduce their final height the mean plasma HRG levels were decreased by 68% (p < 0.005). The effect of progestogens administered during low-dose and high-dose estrogen therapy appeared to be minor. The results from these three studies indicate that estrogens reduce plasma HRG levels in a dose-dependent way. Chemicals/CAS: ethinylestradiol, 57-63-6; histidine, 645-35-2, 7006-35-1, 71-00-1; medrogestone, 977-79-7; Contraceptives, Oral, Hormonal; Estrogens, Conjugated; Ethinyl Estradiol, 57-63-6; histidine-rich proteins; Medrogestone, 977-79-7; Medroxyprogesterone 17-Acetate, 71-58-9; Proteins
Subject
Biology
Adolescent
Age Factors
Aged
Body Height
Child
Comparative Study
Contraceptives, Oral, Hormonal
Dose-Response Relationship, Drug
Estrogens, Conjugated
Ethinyl Estradiol
Female
Gigantism
Human
Medrogestone
Medroxyprogesterone 17-Acetate
Middle Age
Postmenopause
Proteins
Risk
Support, Non-U.S. Gov't
Thromboembolism
To reference this document use:
http://resolver.tudelft.nl/uuid:a0a10f5c-ac4f-437c-89db-2031372ba911
TNO identifier
232915
ISSN
0340-6245
Source
Thrombosis and Haemostasis, 73 (3), 484-487
Series
TNO Preventie en gezondheid, publ. no. 2679
Document type
article